ATE242235T1 - Verfahren zur herstellung von (s-(r*,s*))-g(b)- ((1-(1-oxo-3-(4-piperidinyl)propyl)-3- piperidinyl)carbonyl) amino)-3- pyridinpropansäurederivate - Google Patents

Verfahren zur herstellung von (s-(r*,s*))-g(b)- ((1-(1-oxo-3-(4-piperidinyl)propyl)-3- piperidinyl)carbonyl) amino)-3- pyridinpropansäurederivate

Info

Publication number
ATE242235T1
ATE242235T1 AT00916573T AT00916573T ATE242235T1 AT E242235 T1 ATE242235 T1 AT E242235T1 AT 00916573 T AT00916573 T AT 00916573T AT 00916573 T AT00916573 T AT 00916573T AT E242235 T1 ATE242235 T1 AT E242235T1
Authority
AT
Austria
Prior art keywords
piperidinyl
pyridinepropane
oxo
carbonyl
propyl
Prior art date
Application number
AT00916573T
Other languages
English (en)
Inventor
Judith H Cohen
Michael Justus
Cynthia A Maryanoff
Armin Rossler
Fridtjof Harmen Schroder
Kirk L Sorgi
Frank John Villani Jr
Christian Weh
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE242235T1 publication Critical patent/ATE242235T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
AT00916573T 1999-03-22 2000-03-21 Verfahren zur herstellung von (s-(r*,s*))-g(b)- ((1-(1-oxo-3-(4-piperidinyl)propyl)-3- piperidinyl)carbonyl) amino)-3- pyridinpropansäurederivate ATE242235T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12567199P 1999-03-22 1999-03-22
PCT/US2000/007462 WO2000056730A1 (en) 1999-03-22 2000-03-21 PROCESS FOR PREPARING [S-(R*,S*)] -β -[[[1-[1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES

Publications (1)

Publication Number Publication Date
ATE242235T1 true ATE242235T1 (de) 2003-06-15

Family

ID=22420863

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00916573T ATE242235T1 (de) 1999-03-22 2000-03-21 Verfahren zur herstellung von (s-(r*,s*))-g(b)- ((1-(1-oxo-3-(4-piperidinyl)propyl)-3- piperidinyl)carbonyl) amino)-3- pyridinpropansäurederivate

Country Status (22)

Country Link
US (2) US6515130B1 (de)
EP (1) EP1165543B1 (de)
JP (1) JP2002540108A (de)
KR (1) KR20020019895A (de)
CN (1) CN1351600A (de)
AT (1) ATE242235T1 (de)
AU (1) AU775413B2 (de)
BR (1) BR0010652A (de)
CA (1) CA2368024A1 (de)
CZ (1) CZ20013431A3 (de)
DE (1) DE60003169T2 (de)
DK (1) DK1165543T3 (de)
ES (1) ES2199805T3 (de)
HK (1) HK1046272A1 (de)
HR (1) HRP20010767A2 (de)
HU (1) HUP0201262A3 (de)
MX (1) MXPA01009615A (de)
PT (1) PT1165543E (de)
SK (1) SK13562001A3 (de)
UA (1) UA67832C2 (de)
WO (1) WO2000056730A1 (de)
YU (1) YU74601A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA72755C2 (en) 1999-03-22 2005-04-15 Ortho Mcneil Pharm Inc A method for the preparation of 3-amino-3-arylpropanoates and intermediary compounds for realizing the same
SI1430057T1 (sl) * 2001-09-21 2006-02-28 Sanofi Aventis Substituirani 2-piridinil-6,7,8,9-tetrahidropirimido -(1,2-a)pirimidin-4-onski in 7-piridinil-2,3-dihidroimidazo -(1,2-a)pirimidin-5(1H)onski derivati
PT2744802T (pt) 2011-08-17 2017-03-15 Piramal Imaging Sa Compostos para ligação às glicoproteínas iib/iiia específicas de plaquetas e a sua utilização em imagiologia de trombos
US20160008490A1 (en) 2013-02-12 2016-01-14 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
EP4289819A3 (de) 2013-02-20 2024-01-10 Reuter Chemische Apparatebau e.K. Verfahren zur herstellung von enantiomer angereichertem 3-aminopiperidin
WO2014173855A1 (en) 2013-04-22 2014-10-30 Reuter Chemische Apparatebau Kg Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine
KR102548998B1 (ko) 2020-03-31 2023-06-29 재단법인 아산사회복지재단 혈전영상을 위한 방사성의약품 및 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58243B1 (en) 1983-12-07 1993-08-11 Lonza Ag A process for the preparation of optically-active 3-amino carboxylic acids
US5254573A (en) 1991-10-15 1993-10-19 Monsanto Company Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
EP1106606A3 (de) 1993-09-22 2003-10-22 Fujisawa Pharmaceutical Co., Ltd. N-(3-Piperidinylcarbonyl)-beta-Alanin Derivate als PAF Antagonisten
US5770575A (en) * 1994-03-16 1998-06-23 Ortho Pharmaceutical Corporation Nipecotic acid derivatives as antithrombotic compounds
CA2248809A1 (en) * 1996-03-13 1997-09-18 Fujisawa Pharmaceutical Co., Ltd. N-[(r)-1-{3-(4-piperidyl)propionyl}-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist
PL190796B1 (pl) * 1996-05-01 2006-01-31 Ortho Mcneil Pharm Inc Karboksyamidowe pochodne piperydyny do leczenia zaburzeń zakrzepicowych
US5840961A (en) 1996-07-12 1998-11-24 G. D. Searle & Co. Asymmetric synthesis of chiral beta-amiNo acids
US6066651A (en) * 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders

Also Published As

Publication number Publication date
EP1165543B1 (de) 2003-06-04
HUP0201262A2 (en) 2002-08-28
CZ20013431A3 (cs) 2003-04-16
US20020137937A1 (en) 2002-09-26
CA2368024A1 (en) 2000-09-28
EP1165543A1 (de) 2002-01-02
UA67832C2 (uk) 2004-07-15
HUP0201262A3 (en) 2003-12-29
MXPA01009615A (es) 2003-07-21
DK1165543T3 (da) 2003-09-29
HU0201262D0 (de) 2002-05-29
WO2000056730A1 (en) 2000-09-28
DE60003169D1 (de) 2003-07-10
DE60003169T2 (de) 2005-10-27
ES2199805T3 (es) 2004-03-01
AU3766100A (en) 2000-10-09
PT1165543E (pt) 2003-10-31
HK1046272A1 (zh) 2003-01-03
SK13562001A3 (sk) 2002-08-06
BR0010652A (pt) 2002-07-16
KR20020019895A (ko) 2002-03-13
AU775413B2 (en) 2004-07-29
CN1351600A (zh) 2002-05-29
YU74601A (sh) 2004-05-12
HRP20010767A2 (en) 2002-12-31
JP2002540108A (ja) 2002-11-26
US6515130B1 (en) 2003-02-04

Similar Documents

Publication Publication Date Title
ATE419239T1 (de) Verfahren zur herstellung von 4-phenoxy chinolin derivaten
ATE258927T1 (de) Verbessertes verfahren zur herstellung von n- substituierte aminotetraline
ATE145891T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür
DE602005026827D1 (de) Verfahren zur herstellung von isoindolderivaten
ATE242241T1 (de) Imidazopyridinderivate und verfahren zu ihrer herstellung
ATE242235T1 (de) Verfahren zur herstellung von (s-(r*,s*))-g(b)- ((1-(1-oxo-3-(4-piperidinyl)propyl)-3- piperidinyl)carbonyl) amino)-3- pyridinpropansäurederivate
DE60031391D1 (de) Verfahren zur herstellung von carbonsäuresalzen aus primären alkoholen
DE60132053D1 (de) Verfahren zur herstellung von amidverbindungen
ATE348810T1 (de) Verfahren zur herstellung von 2-aminomethyl- halogen-pyridinen
DE69920708D1 (de) Verfahren zur herstellung von 1,4-bis[[2-(dimethylamino)ethyl amino]-5,8-dihydroxyanthracene-9,10-dion
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE310735T1 (de) Verfahren zur herstellung von spirocyclischen tetronsäurederivaten
ATE380173T1 (de) Verfahren zur herstellung von (2s,3r,4s)-4- hydroxyisoleucin und analoga
ATE309198T1 (de) Fungizide mit einer fluorovinyl-oder fluoropropenyloxyphenyloxim-einheit und ein verfahren zu ihrer herstellung.
ATE280769T1 (de) Verfahren zur herstellung von vitronectin- rezeptorantagonisten
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE388156T1 (de) Verfahren zur herstellung von ethylen-1,2- diphosphonsäuren
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
ATE342254T1 (de) Verfahren zur herstellung von derivaten von [(1,5-diaryl)pyrazol-3-ylöpropansäure
DE60001151D1 (de) Lösungsmittelfreies verfahren zur herstellung von thiuram-disulfiden
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride
ATE404540T1 (de) Verfahren zur herstellung von 1-substituierten 5- chlor-4methylpyrazolen
DE69733716D1 (de) Verfahren zur herstellung von imidazolderivaten
ATE240945T1 (de) Verfahren zur herstellung von 4-((2',5'-diamino- 6'-halogenpyrimidin-4'-yl)amino)-cyclopent-2- enylmethanolen
ATE223377T1 (de) Verfahren zur herstellung von difluoracetophenon- derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165543

Country of ref document: EP

REN Ceased due to non-payment of the annual fee